SANGAMO THERAPEUTICS INC
SGMO
SGMO was delisted on the 4th of May, 2026.
115 hedge funds and large institutions have $642M invested in SANGAMO THERAPEUTICS INC in 2013 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 42 increasing their positions, 31 reducing their positions, and 18 closing their positions.
789% more call options, than puts
Call options by funds: $93.6M | Put options by funds: $10.5M
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
57% more capital invested
Capital invested by funds: $408M → $642M (+$234M)
35% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 31
22% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 18
4% more funds holding
Funds holding: 111 → 115 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
+$12.9M |
| 2 |
PCA
Private Capital Advisors
Darien,
Connecticut
|
+$12.2M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$11.2M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.58M |
| 5 |
Jennison Associates
New York
|
+$4.85M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$10.1M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$6.08M |
| 3 |
PC
PointState Capital
New York
|
-$2.91M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$2.05M |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$1.85M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
126
Arrowstreet Capital
Boston,
Massachusetts
| – | -$160K | -15,239 | Closed |
|
127
Tudor Investment Corp
Stamford,
Connecticut
| – | -$143K | -13,600 | Closed |
|
|
AL
128
Airain Ltd
St. Peter Port,
Guernsey
| – | -$139K | -13,268 | Closed |
|
|
JG
129
Jefferies Group
New York
| – | -$118K | -11,224 | Closed |
|
|
HCM
130
Highbridge Capital Management
New York
| – | -$109K | -10,270 | Closed |
|
|
TF
131
Trutina Financial
Bellevue,
Washington
| – | -$87K | -8,300 | Closed |
|
|
TRCT
132
Tower Research Capital (TRC)
New York
| – | -$17.7K | -1,535 | -100% |
|
133
Creative Planning
Overland Park,
Kansas
| – | -$4K | -400 | Closed |
|
SGMO Hedge Fund Activity: Q4 2013 in Review
115 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q4 2013, worth a combined $642M — up 57% from $408M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new SGMO positions and 18 closed out — a net gain of 4 holders — while 42 added to existing stakes and 31 trimmed.
The largest buyer was SAC Capital Advisors, opening a new position worth an estimated $12.9M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $10.1M sold.
- 115 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q4 2013, up from 111 in Q3 2013.
- Funds reported $642M of SANGAMO THERAPEUTICS INC stock for Q4 2013, up 57% quarter-over-quarter.
- 22 funds opened new SANGAMO THERAPEUTICS INC positions in Q4 2013 and 18 closed out, a net change of +4 holders.
- The largest SANGAMO THERAPEUTICS INC buyer in Q4 2013 was SAC Capital Advisors, an estimated $12.9M added.
- The largest SANGAMO THERAPEUTICS INC seller in Q4 2013 was Perceptive Advisors, an estimated $10.1M sold.
Based on aggregated 13F filings for Q4 2013.